ATE290017T1 - Hochgereinigter cytokin-aktivierender faktor und verfahren zu seiner verwendung - Google Patents

Hochgereinigter cytokin-aktivierender faktor und verfahren zu seiner verwendung

Info

Publication number
ATE290017T1
ATE290017T1 AT00947517T AT00947517T ATE290017T1 AT E290017 T1 ATE290017 T1 AT E290017T1 AT 00947517 T AT00947517 T AT 00947517T AT 00947517 T AT00947517 T AT 00947517T AT E290017 T1 ATE290017 T1 AT E290017T1
Authority
AT
Austria
Prior art keywords
highly purified
activate factor
purified cytokine
cytokine
activate
Prior art date
Application number
AT00947517T
Other languages
English (en)
Inventor
Subramanian Iyer
Lance Nguyen
Dauh-Rurng Wu
Ruye Xing
Original Assignee
Arkion Life Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkion Life Sciences filed Critical Arkion Life Sciences
Application granted granted Critical
Publication of ATE290017T1 publication Critical patent/ATE290017T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/852Sperm
    • Y10S530/853Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00947517T 1999-07-23 2000-07-19 Hochgereinigter cytokin-aktivierender faktor und verfahren zu seiner verwendung ATE290017T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14531799P 1999-07-23 1999-07-23
US19761900P 2000-04-14 2000-04-14
PCT/US2000/019643 WO2001007472A1 (en) 1999-07-23 2000-07-19 Highly purified cytokine activating factor and methods of use

Publications (1)

Publication Number Publication Date
ATE290017T1 true ATE290017T1 (de) 2005-03-15

Family

ID=26842849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00947517T ATE290017T1 (de) 1999-07-23 2000-07-19 Hochgereinigter cytokin-aktivierender faktor und verfahren zu seiner verwendung

Country Status (18)

Country Link
US (2) US6420337B1 (de)
EP (1) EP1198475B1 (de)
JP (1) JP4763193B2 (de)
CN (1) CN1376163A (de)
AR (1) AR033340A1 (de)
AT (1) ATE290017T1 (de)
AU (1) AU778239B2 (de)
BR (1) BR0013043A (de)
CA (1) CA2379251A1 (de)
CO (1) CO5290297A1 (de)
DE (1) DE60018426T2 (de)
ES (1) ES2239019T3 (de)
IL (1) IL147716A0 (de)
MX (1) MXPA02000779A (de)
MY (1) MY125980A (de)
NZ (1) NZ516744A (de)
TW (1) TWI250164B (de)
WO (1) WO2001007472A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1279972C (zh) * 2002-02-11 2006-10-18 阿基昂生命科学有限责任公司 纯化的细胞因子抑制因子
US20040005327A1 (en) * 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
WO2006069779A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Preparing of peptides with excellent solubility
US20080071067A1 (en) * 2006-09-20 2008-03-20 Avigenics, Inc. Methods of purifying proteins from egg white
US7852810B1 (en) * 2007-01-03 2010-12-14 Sprint Spectrum L.P. Dynamic adjustment of forward-link frame-error-rate (FFER) target
US7813323B1 (en) 2007-06-13 2010-10-12 Sprint Spectrum L.P. Dynamic adjustment of reverse-link frame-error-rate (RFER) target based on reverse-link RF conditions
US8107988B1 (en) 2008-07-25 2012-01-31 Sprint Spectrum L.P. Conducting power control based on reverse-link RF conditions
EP2331184B1 (de) * 2008-09-05 2016-12-14 Cardiopolymers, Inc Vorrichtung zur kapselbildung in gewebe
US8477686B1 (en) 2009-09-10 2013-07-02 Sprint Spectrum L.P. Automatic increase of target frame error rate for duration based on call drop timer
US8537700B1 (en) 2010-04-19 2013-09-17 Sprint Spectrum L.P. Identifying and selectively controlling reverse-noise contribution on a per-access-terminal basis
US8290532B1 (en) 2010-04-19 2012-10-16 Sprint Spectrum L.P. Selectively conducting reverse-link power control and call admission control
CN104288769B (zh) * 2014-09-17 2017-09-29 陕西建华生物制药有限公司 一种西药外用膏剂及其制备方法
JP5894695B1 (ja) * 2015-05-25 2016-03-30 ホーユー株式会社 ウズラの卵アレルギーの抗原
US10632158B2 (en) 2016-06-23 2020-04-28 IgY Nutrition Use of a hyperimmune egg product to prevent and treat dysbiosis
MX2019009554A (es) 2017-02-13 2020-01-30 Us Agriculture Producto de huevo hiperinmunizado para el tratamiento de enteritis necrotica en aves de corral.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119279D0 (en) * 1991-09-10 1991-10-23 Ici Plc Modification of lignin synthesis in plants
AU5900198A (en) * 1996-12-20 1998-07-17 Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulation of vesicular release

Also Published As

Publication number Publication date
US20030143190A1 (en) 2003-07-31
BR0013043A (pt) 2002-04-30
MXPA02000779A (es) 2003-10-15
AR033340A1 (es) 2003-12-17
EP1198475B1 (de) 2005-03-02
IL147716A0 (en) 2002-08-14
AU6110600A (en) 2001-02-13
ES2239019T3 (es) 2005-09-16
JP4763193B2 (ja) 2011-08-31
US6420337B1 (en) 2002-07-16
NZ516744A (en) 2004-01-30
WO2001007472A1 (en) 2001-02-01
JP2003506019A (ja) 2003-02-18
TWI250164B (en) 2006-03-01
CN1376163A (zh) 2002-10-23
EP1198475A1 (de) 2002-04-24
EP1198475A4 (de) 2003-05-14
DE60018426D1 (de) 2005-04-07
MY125980A (en) 2006-09-29
AU778239B2 (en) 2004-11-25
CO5290297A1 (es) 2003-06-27
DE60018426T2 (de) 2006-05-11
CA2379251A1 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
DE60044718D1 (de) Mehrfrequenz-multipol und verfahren zu seiner verwendung
DE60013027D1 (de) Bauteil und Verfahren zu seiner Herstellung
DE60027698D1 (de) Lasttragendes osteoimplantat und verfahren zu seiner herstellung
DE60023023D1 (de) Zirkoniumdioxidsol und verfahren zu seiner herstellung
DE69832409D1 (de) Wiederanbringbares notizblatt und verfahren zu seiner herstellung
DE60031036D1 (de) Struktureller Körper und Verfahren zu seiner Herstellung
DE69938197D1 (de) Vliesstoff hoher festigkeit und verfahren zu seiner herstellung
DE60032193D1 (de) Verfahren und System zur Auswahl erkannter Wörter bei der Korrektur erkannter Sprache
DE69839778D1 (de) Widerstand und verfahren zu seiner herstellung
ATE372570T1 (de) Umgossener transponder und verfahren zu dessen herstellung
DE60033157D1 (de) Überschalldiffusor mit externer kompression und verfahren zu seiner planung
EP1365829A4 (de) Emboli-filtrationssystem mit integraler strebenanordnung und verfahren zu seiner verwendung
DE60013321D1 (de) Antimikrobieller absorbierender artikel und verfahren zu seiner herstellung und verwendung
DE10080587T1 (de) Schutzüberzug und Verfahren zu dessen Herstellung
ATE290017T1 (de) Hochgereinigter cytokin-aktivierender faktor und verfahren zu seiner verwendung
DE69822873D1 (de) Zusammensetzungen und verfahren zur gewichtsverringerung
DE69810786D1 (de) Keramischer heissgasfilter und verfahren zu seiner herstellung
DE69833756D1 (de) Elektronisches bauelement und verfahren zu seiner herstellung
DE60019691D1 (de) Siliziumkarbid und Verfahren zu seiner Herstellung
DE60033224D1 (de) Drucksystem und Verfahren dafür
DE60008571D1 (de) Aufbohrbarer aufblasbarer packer und verfahren zur dessen verwendung
DE69918995D1 (de) Chelat-bildender filter und verfahren zu seiner herstellung
ATE522205T1 (de) Testosteronhaltiges transdermales therapeutisches system und verfahren zu seiner herstellung
DE69707642D1 (de) Keramischer zünder und verfahren zu seiner verwendung
DE60128697D1 (de) Keramischer filter und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties